Statin Modulation of Human T-Cell Proliferation, IL-1 and IL-17 Production, and IFN- T Cell Expression: Synergy with Conventional Immunosuppressive Agents
Figure 1
Cell viability was assessed at all concentrations of statins. The percentage viability is compared in the presence (filled bars) or absence of mevalonate (clear bars). * denotes a statistical difference between viability of cells in different concentrations of statins (), and ⌀ indicates a difference in viability with and without mevalonate ().
